Lu Li, Xu Kai, Shi Lin, Dou Weiqiang, Liu Kai, Ma Hong, Xie Lixiang, Zhang Chao, Lu Cailuan
Department of Radiology, Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu Province, China.
GE Healthcare, MR Research China, Beijing, China.
Biomed Res Int. 2021 Feb 25;2021:6646416. doi: 10.1155/2021/6646416. eCollection 2021.
This study investigated potential imaging biomarkers for predicting the efficacy of deep brain stimulation (DBS) of the subthalamic nucleus (STN) in patients with Parkinson's disease (PD). A total of 59 PD patients and 50 healthy control subjects underwent high-resolution 3-dimensional T1-weighted brain magnetic resonance imaging. Bilateral STN volumes were compared between the 2 groups, and a correlation analysis was performed to assess the relationship between bilateral STN volumes or intracranial volume (ICV) and pre- or postoperative clinical scale scores. The results showed that the left STN volume differed significantly between PD patients and controls. In patients, the left STN volume was negatively correlated with pre- and postoperative quality of life scores and positively correlated with Mini-mental State Examination (MMSE) and Montreal Cognitive Assessment scores; ICV was also positively correlated with the MMSE score. These findings indicate that changes in the left STN volume are a useful biomarker for evaluating the clinical outcome of PD patients following DBS.
本研究调查了潜在的影像学生物标志物,以预测帕金森病(PD)患者丘脑底核(STN)深部脑刺激(DBS)的疗效。共有59例PD患者和50名健康对照者接受了高分辨率三维T1加权脑磁共振成像。比较了两组之间的双侧STN体积,并进行了相关性分析,以评估双侧STN体积或颅内体积(ICV)与术前或术后临床量表评分之间的关系。结果显示,PD患者与对照组之间左侧STN体积存在显著差异。在患者中,左侧STN体积与术前和术后生活质量评分呈负相关,与简易精神状态检查表(MMSE)和蒙特利尔认知评估评分呈正相关;ICV也与MMSE评分呈正相关。这些发现表明,左侧STN体积的变化是评估PD患者DBS术后临床结局的有用生物标志物。